8-K
Current Report
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001193125-23-199683
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading d519359d8k.htm…